More recently, Li et al. found that the repression of miR-21 expression sensitizes glioblastoma cells to VM-26 treatment via leucine rich repeat interacting protein (LRRFIP1)-mediated inhibition of NF-κB signaling, a principal mechanism of tumor chemoresistance [18]. This evidence concerns the gene LRRFIP1 and glioblastoma.